U.S., June 3 -- ClinicalTrials.gov registry received information related to the study (NCT07620717) titled 'Early Diagnosis of PROstate CANcer for Black Men' on May 26.
Brief Summary: PROCAN-B+ is a mixed-methods, two-arm, multi-centre randomised controlled trial evaluating a co-designed, peer-led intervention to encourage informed help-seeking and engagement with prostate cancer health checks and Prostate Specific Antigen (PSA) testing among Black men aged 45 years and over with no history of prostate cancer.
The study will recruit 300 participants across three UK sites: North East England including Leeds, Scotland, and London. Following eligibility screening and baseline data collection, participants will be individually randomised in a...